TORONTO--(BUSINESS WIRE)-- #AI--Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today that its founder and Chief Innovation Officer, Brendan Frey, Ph.D., F.R.S.C., will present at the 2023 Elevate Festival in Toronto on Tuesday, September 26, 2022, at 6:35 PM EST. Brendan's remarks, titled Beacons of Hope: AI in Medicine will highlight recent advances in the use of Artificial Intelligence (AI) and deep learning for drug di
Deep Genomics is a Canada-based biopharmaceutical company that researches and develops AI-driven RNA therapeutics for the treatment of genetic conditions.